NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. (“Lev” or the “Company”) (OTCBB: LEVP) announced today that Joshua Schein, Ph.D., Lev’s Chief Executive Officer, will present at the C.E. Unterberg, Towbin Life Sciences Conference on Monday, October 30th, 2006 at 8:30 a.m. EST at The New York Palace Hotel in New York. Dr. Schein will provide an overview of the Company and an update on its clinical development programs. The Conference, being held on October 30 and 31st, features emerging life sciences companies.
